Co-administration of dexamethasone increases severity and accelerates onset day of neutropenia in bladder cancer patients on methotrexate, vinblastine, adriamycin and cisplatin chemotherapy: a retrospective cohort study

BACKGROUND: Bladder cancer patients receiving methotrexate, vinblastine, adriamycin and cisplatin (MVAC) chemotherapy are co-administered with dexamethasone as an anti-emetic. We examined whether or not dexamethasone affects the severity and onset day of MVAC-induced severe neutropenia. METHODS: Thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Itai, Shingo, Suga, Yukio, Hara, Yusuke, Izumi, Kouji, Maeda, Yuji, Kitagawa, Yasuhide, Ishizaki, Junko, Shimada, Tsutomu, Mizokami, Atsushi, Sai, Yoshimichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225533/
https://www.ncbi.nlm.nih.gov/pubmed/28097015
http://dx.doi.org/10.1186/s40780-016-0072-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225533/
https://www.ncbi.nlm.nih.gov/pubmed/28097015
http://dx.doi.org/10.1186/s40780-016-0072-5

Ejemplares similares